AT PMWC, FDA Commissioner Hamburg Discusses LDT Regulation, Personalized Medicine Advancements | GenomeWeb

MOUNTAIN VIEW, Calif. (GenomeWeb) – At the Personalized Medicine World Conference on Wednesday, US Food and Drug Administration Commissioner Margaret Hamburg said that the agency will carefully review the public comments it receives in response to its draft proposal to regulate laboratory-developed tests. However, she couldn't predict when the agency would finalize the document.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.